The Standard Care Versus Celecoxib Outcome Trial

PHASE4CompletedINTERVENTIONAL
Enrollment

7,297

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

August 31, 2015

Study Completion Date

August 31, 2015

Conditions
OsteoarthritisRheumatoid Arthritis
Interventions
DRUG

Celecoxib

200-400mg daily in divided doses

DRUG

Diclofenac

prescribed medication taken orally

Trial Locations (10)

5000

University of Southern Denmark, Odense

3703 CD Zeist

Julius Clinical Research, Zeist

AB25 2ZN

University of Aberdeen, Aberdeen

B15 2TT

University of Birmingham, Birmingham

DD1 9SY

University of Dundee, Dundee

EH4 2XU

University of Edinburgh, Edinburgh

G11 6NT

University of Glasgow, Glasgow

IV2 3JH

NHS Highlands, Inverness

NG7 2UH

University of Nottingham, Nottingham

OX1 2ET

University of Oxford, Oxford

All Listed Sponsors
collaborator

University of Glasgow

OTHER

collaborator

University of Nottingham

OTHER

lead

University of Dundee

OTHER

NCT00447759 - The Standard Care Versus Celecoxib Outcome Trial | Biotech Hunter | Biotech Hunter